Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26036063 | 0.85 | MAPT (0.37) | MAPTALOX15TSHRL3MBTL1 | |
| SCHEMBL25836356 | 0.80 | MAPT (0.37) | MAPTALOX15TSHR | |
| SCHEMBL25839769 | 0.79 | L3MBTL1 (0.41) | MAPTALOX15TSHRL3MBTL1 | |
| SCHEMBL25836233 | 0.70 | MAPT (0.39) | MAPTALOX15TSHR | |
| SCHEMBL25836103 | 0.70 | MAPT (0.39) | MAPTALOX15TSHR | |
| SCHEMBL25840379 | 0.69 | CNR1 (0.33) | — | |
| SCHEMBL26032102 | 0.69 | MAPT (0.38) | MAPTALOX15TSHR | |
| SCHEMBL26033614 | 0.69 | MAPT (0.38) | MAPTALOX15TSHR | |
| SCHEMBL26036521 | 0.69 | HPGD (0.40) | MAPTALOX15TSHRL3MBTL1 | |
| SCHEMBL26035286 | 0.66 | SLC6A5 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230226193-A1 | LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS | Arrowhead Pharmaceuticals, Inc. | 2023-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230226193-A1 | LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS | CPT1B, MUSK, MYLK2 | MAPT 3973/4885ALOX15 1471/4885TSHR 1324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.